Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Original Article

Volume 2, Number 1, February 2012, pages 32-38


T Wave and QRS Complex Alternans During Stress ECG Testing According to the Presence or Absence of Diabetes Mellitus

Figure

Figure 1.
Figure 1. Methods for the interval selection for the detection of TWA: Global (entire record) and Local (a set of windows).

Tables

Table 1. Demographic Characteristics and Risk Factor Distribution for the Whole Group of Patients
 
Clinical variableDistribution
n = 107
SD: standard deviation; BMI: body mass index; AH: arterial hypertension; MI: myocardial infarction; PCI: percutaneous coronary intervention; n: number.
Age - mean ± SD62.8 ± 10.3
Male - n (%)45 (42%)
BMI - mean ± SD27.9 ± 4.4
AH - n (%)96 (90%)
DM - n (%)39 (36%)
Dyslipidemia - n (%)87 (81%)
Family history of CAD - n (%)11 (10%)
Present smokers - n (%)16 (15%)
Ex-smokers - n (%)25 (23%)
Angina pectoris - n (%)86 (80%)
History of MI - n (%)18 (17%)
Positive stress ECG test - n (%)34 (32%)
AS-CAD - n (%)48 (45%)
PCI - n (%)40 (37%)
Coronary artery bypass grafting - n (%)10 (9%)

 

Table 2. Differences in TWA and QRSA Values Measured With 60 and 128 RR Interval Window
 
Parameter60 RR128 RRStat. sign (P)
TWA1.8 ± 0.771.48 ± 0.82P < 0.001
QRSA1.43 ± 0.741.16 ± 0.68P < 0.001

 

Table 3. Comparison TWA and QRSA (Measured With 60 and 128 RR Interval Window) Between Patients With Positive or Negative Stress ECG Test in the Whole Group Of Patients and in the Subgroups With or Without DM
 
Whole group n = 107Stress posStress negStat. sign (P)
TWA-602.32 ± 0.681.22 ± 0.59< 0.001
QRSA-601.79 ± 0.911.26 ± 0.710.003
TWA-1282.03 ± 0.581.22 ± 0.79< 0.001
QRSA-1281.62 ± 0.850.95 ± 0.76< 0.001
Subgroup DM n = 39
TWA-602.43 ± 0.651.24 ± 0.72< 0.001
QRSA-602.29 ± 0.731.56 ± 0.820.02
TWA-1282.07 ± 0.271.04 ± 0.690.001
QRSA-1281.93 ± 0.881.04 ± 0.690.006
Subgroup no DM n =68
TWA-602.25 ± 0.721.73 ± 0.610.004
QRSA-601.45 ± 0.431.1 ± 0.390.04
TWA-1282 ± 0.731.31 ±0.620.002
QRSA-1281.4 ± 0.550.9 ± 0.250.013

 

Table 4. Comparison TWA and QRSA (Measured With 60 and 128 RR Interval Window) Between Patients With or Without PCI in the Whole Group of Patients and in the Subgroups With or Without DM
 
Whole group n = 97PCIno PCIStat. sign (P)
TWA-602.18 ± 0.781.25 ± 0.69< 0.001
QRSA-601.85 ± 0.81.18 ± 0.81< 0.001
TWA-1281.85 ± 0.741.25 ± 0.74< 0.001
QRSA-1281.55 ± 0.750.93 ± 0.46< 0.001
Subgroup DM n = 34
TWA-602 ± 1.041.48 ± 0.77ns
QRSA-602.07 ± 0.921.68 ± 1.07ns
TWA-1281.71 ± 0.831.26 ± 0.9ns
QRSA-1281.71 ± 0.911.16 ± 0.94ns
Subgroup no DM n =63
TWA-602.27 ± 0.61.64 ± 0.62< 0.001
QRSA-601.73 ± 0.620.99 ± 0.36< 0.001
TWA-1281.92 ± 0.691.26 ± 0.52< 0.001
QRSA-1281.46 ± 0.650.79 ± 0.21< 0.001